Mabtas 500mg/50ml (Rituximab) Injection - Biosimilar for Cancer & Autoimmune Disorders

Mabtas 500mg/50ml is a high-quality biosimilar of Rituximab, used in the treatment of non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), and other autoimmune diseases. It works by targeting CD20-positive B-cells, helping to reduce inflammation and slow cancer progression.

✅ Composition: Rituximab (500mg/50ml)
✅ Form: Sterile Injection (Single-use vial)
✅ Manufacturer: Trusted Pharma Brand
✅ Storage: Store at 2°C–8°C, protect from light
✅ Prescription Required: Yes

Why Buy Mabtas 500mg/50ml from Us?
✔ WHO-GMP Certified Supplier
✔ Cold Chain Shipping Assurance
✔ Competitive Wholesale Pricing
✔ Global Export Available

FAQ Section Mabtas 500mg/50ml

Q1: What is Mabtas 500mg/50ml used for?
A: Mabtas is used to treat blood cancers (NHL, CLL) and autoimmune disorders (RA, pemphigus vulgaris).

Q2: How is Mabtas administered?
A: It is given as an intravenous (IV) infusion under medical supervision.

Q3: Are there side effects of Mabtas?
A: Common side effects include fever, chills, fatigue, and low blood cell counts. Consult a doctor before use.

Q4: Can I buy Mabtas 500mg/50ml without a prescription?
A: No, it is a prescription-only medication.

Q5: Do you ship Mabtas internationally?
A: Yes, we offer worldwide shipping with cold chain compliance.